Cover Image
市場調查報告書

肝損傷:全球臨床實驗檢討

Hepatic Injury Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 239407
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
肝損傷:全球臨床實驗檢討 Hepatic Injury Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月28日 內容資訊: 英文 67 Pages
簡介

本報告提供肝損傷相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7·E7各國的臨床實驗狀況,各地區、Phase、階段別進行狀況,並彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 肝損傷
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量; 亞太地區
    • 主要國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美

G7各國的臨床實驗數量:肝損傷臨床實驗數量上消化管疾病臨床實驗數量所佔比例

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:肝損傷臨床實驗數量上消化管疾病臨床實驗數量所佔比例

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗的主要參與企業 - 肝損傷治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • 武田藥品工業
    • Pfizer Inc.
    • Ocera Therapeutics, Inc.
    • Novartis AG
    • McNEIL-PPC, Inc.
    • Jubilant Life Sciences Limited
    • Indivior PLC
    • Ikaria Holdings, Inc.
    • Golden Biotechnology Corp.
    • Cumberland Pharmaceuticals, Inc.
  • 有代表性的研究機關/醫院臨床實驗概要
    • Children's Medical Center
    • Chonbuk National University Hospital
    • Denver Health and Hospital Authority
    • Hillerod Hospital
    • Seoul National University Hospital
    • The First Affiliated Hospital of Sun Yat-sen University
    • Thomas Jefferson University
    • University of Alabama at Birmingham
    • University of Texas Southwestern Medical Center at Dallas

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2667CTIDB

GlobalData's clinical trial report, "Hepatic Injury Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hepatic Injury
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Hepatic Injury to Gastrointestinal Clinical Trials
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hepatic Injury to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hepatic Injury
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hepatic Injury Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Ocera Therapeutics, Inc.
      • Clinical Trial Overview of Ocera Therapeutics, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • McNEIL-PPC, Inc.
      • Clinical Trial Overview of McNEIL-PPC, Inc.
      • Jubilant Life Sciences Limited
      • Clinical Trial Overview of Jubilant Life Sciences Limited
      • Indivior PLC
      • Clinical Trial Overview of Indivior PLC
      • Ikaria Holdings, Inc.
      • Clinical Trial Overview of Ikaria Holdings, Inc.
      • Golden Biotechnology Corp.
      • Clinical Trial Overview of Golden Biotechnology Corp.
      • Cumberland Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cumberland Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Children's Medical Center
      • Clinical Trial Overview of Children's Medical Center
      • Chonbuk National University Hospital
      • Clinical Trial Overview of Chonbuk National University Hospital
      • Denver Health and Hospital Authority
      • Clinical Trial Overview of Denver Health and Hospital Authority
      • Hillerod Hospital
      • Clinical Trial Overview of Hillerod Hospital
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • The First Affiliated Hospital of Sun Yat-sen University
      • Clinical Trial Overview of The First Affiliated Hospital of Sun Yat-sen University
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • University of Alabama at Birmingham
      • Clinical Trial Overview of University of Alabama at Birmingham
      • University of Texas Southwestern Medical Center at Dallas
      • Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hepatic Injury Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proportion of Hepatic Injury to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Hepatic Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hepatic Injury to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hepatic Injury Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hepatic Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by McNEIL-PPC, Inc., 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Jubilant Life Sciences Limited, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior PLC, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Holdings, Inc., 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Golden Biotechnology Corp., 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Medical Center, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Chonbuk National University Hospital, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Denver Health and Hospital Authority, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillerod Hospital, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by The First Affiliated Hospital of Sun Yat-sen University, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2015*
  • Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015*

List of Figures

  • Hepatic Injury Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Proportion of Hepatic Injury to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Hepatic Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hepatic Injury to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hepatic Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hepatic Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hepatic Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top